Bryan Hubbard, Executive Director of the American Ibogaine Initiative and former head of Kentucky's Opioid Abatement Advisory Commission, discusses groundbreaking therapies using ibogaine for opioid addiction and brain health. He reveals how ibogaine can reset neurochemistry and explores its potential in treating conditions like Parkinson's disease. The conversation delves into the spiritual and political aspects of psychedelic medicine, highlighting Texas as a new frontier for research and the urgent need for innovative treatment options in combating the opioid crisis.
01:03:47
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
insights INSIGHT
Ibogaine's Rapid Brain Reset
Ibogaine can reset brain neurochemistry in 36-48 hours, compared to 18 months via abstinence.
It shows promise for treating opioid addiction, traumatic brain injury, and Parkinson's disease.
question_answer ANECDOTE
Parkinson's Recovery with Ibogaine
A Parkinson's patient near euthanasia regained motor function through daily ibogaine titration.
He moved from bedfast to riding a bicycle daily after treatment.
insights INSIGHT
Ibogaine's Strategic Brain Pharmacology
Ibogaine's matrix pharmacology strategically resets dopamine and serotonin pathways.
This interrupts opioid addiction by restoring natural neurochemical balance and brain function.
Get the Snipd Podcast app to discover more snips from this episode
Stephen King is a prolific American author renowned for his mastery of the horror, supernatural fiction, and suspense genres. With over 60 novels and numerous short stories, King has captivated readers worldwide with his gripping narratives and vividly drawn characters. His works often explore the darker aspects of human nature, delving into themes of fear, isolation, and the battle between good and evil. Many of his stories are set in his home state of Maine, adding a sense of authenticity and familiarity to his fictional worlds. King's impact on popular culture is undeniable, with numerous adaptations of his works into films, television series, and comic books. His ability to connect with readers on a deep emotional level has solidified his place as one of the most influential and best-selling authors of all time.
In this episode of The Psychedelic Podcast, Paul F. Austin welcomes Bryan Hubbard, a prominent advocate for psychedelic-assisted therapies, particularly ibogaine in the treatment of opioid addiction and mental health disorders.
Update (May 2025): Days before this episode's release, the Texas House approved a Senate-backed bill to fund ibogaine research through a public-private partnership aimed at securing FDA approval. This vote marks a major milestone in the movement Bryan describes throughout this conversation.
Bryan shares his journey from leading Kentucky's Opioid Abatement Advisory Commission to spearheading breakthrough ibogaine research initiatives in Texas. He articulates ibogaine's unique neurological properties, discussing how it can reset brain neurochemistry in 36 hours and potentially treat conditions from traumatic brain injury to Parkinson's disease. The conversation explores the spiritual dimensions of ibogaine experiences, the political landscape surrounding psychedelic medicine, and Bryan's ongoing efforts to medicalize ibogaine through FDA drug development trials, highlighting Texas as the next frontier for this life-saving research.
W. Bryan Hubbard is the Executive Director of the American Ibogaine Initiative. He is the first and former Chairman and Executive Director of the Kentucky Opioid Abatement Advisory Commission. He concurrently served as Special Counsel to the Kentucky Attorney General’s Office of Medicaid Fraud and Abuse Control and was its prior Executive Director. He served on the Kentucky Judicial Commission on Mental Health, the Kentucky Child Support Guidelines Commission, Mine Safety Review Board, and the Kentucky Office of Drug Control Policy’s Recovery Ready Communities Advisory Council. He previously served as Commissioner of the Kentucky Department of Income Support wherein he led the Commonwealth’s Social Security Disability and Child Support Enforcement systems. He practiced workers’ compensation law representing Walmart, Tyson Foods, and Tennessee Valley Authority for sixteen years. During his practice years, he observed the predacious onset of Kentucky’s Opioid Epidemic amid generational joblessness, poverty, disability, and substance use. He was raised in Virginia’s coalfields and is the proud grandson of two grade-school educated coal miners on whose shoulders he stands.
Highlights:
Why ibogaine interrupts addiction instantly
The Stanford study that changed everything
Resetting brain neurochemistry in 36 hours
From Parkinson's to PTSD: Ibogaine's broad applications
The spiritual awakening dimension of treatment
How pharmaceutical interests block breakthrough medicine
Kentucky's lost opportunity: $42 million for research
Texas as the new frontier for ibogaine medicalization
The Psychedelic Podcast 